Close
  Indian J Med Microbiol
 

Figure 6: Effects of MAPK pathway inhibitors on the activity of CF in AGS cells. 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay was used to evaluate cell viability after co-treating AGS cells with CF and (a) SP600125, (b) PD98059, or (c) SB203580 for 24 h. Results are presented as the means ± standard error means. **P < 0.01 versus untreated controls. #P < 0.05 for comparisons between the treatments. CF: Carthami flos; CTRL: Control

Figure 6: Effects of MAPK pathway inhibitors on the activity of CF in AGS cells. 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay was used to evaluate cell viability after co-treating AGS cells with CF and (a) SP600125, (b) PD98059, or (c) SB203580 for 24 h. Results are presented as the means ± standard error means. **<i>P</i> < 0.01 versus untreated controls. <sup>#</sup><i>P</i> < 0.05 for comparisons between the treatments. CF: <i>Carthami flos</i>; CTRL: Control